ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
820,991
Share change
+409,322
Total reported value
$3,291,000
Price per share
$4.00
Number of holders
15
Value change
+$1,624,795
Number of buys
13
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q4 2020

As of 31 Dec 2020, ARCA BIOPHARMA INC - COM (ABIO) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 820,991 shares. The largest 10 holders included BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, Tekla Capital Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, and NORTHERN TRUST CORP. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.